New York / New York / United States
Michael Hutchinson MD, PhD is a neurologist at New York Core Neuroscience serving patients in New York, New York. A graduate of the highly competitive PhD-to-MD program at the University of Miami, Dr. Hutchinson received his medical degree in 1988. During his residency training at the University of Washington, he developed a method of treating status epilepticus (the most lethal form of epilepsy) that is now the standard of care in the US. In addition to extensive training in multiple sclerosis, Dr. Hutchinson completed a two-year fellowship in neuroimaging at UCLA. He is currently Senior Faculty at the Icahn School of Medicine at Mount Sinai, New York. Dr. Hutchinson is board certified in both neurology and neuroimaging and is President of the American Society of Neuroimaging. He holds a PhD in molecular physics in addition to his medical degree. A medical pioneer, Dr. Hutchinson proposed a novel treatment for status epilepticus in 1990, now the standard of care. He was the first to use cholinesterase inhibitors for the dementia of Parkinson’s disease (1995) and developed a novel approach to treating acute relapses in multiple sclerosis (2002). He is the inventor of the parallel MRI (1987), which is now the world standard for magnetic resonance imaging.
